November 25, 2020
BURLINGTON, Ontario – November 25, 2020 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it signed a definitive agreement with ESJ Enterprises, LLC. RDT...
November 19, 2020
BURLINGTON, Ontario – November 19, 2020 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has, as of November 18, 2020, received a Revocation...
September 29, 2020
BURLINGTON, Ontario – September 29, 2020 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has amended the agreement with Aphria Inc. (TSE:APHA, Nasdaq:APHA)...
August 13, 2020
Burlington, Ontario – August 13, 2020 – Rapid Dose Therapeutics Corp. trading on the Canadian Securities Exchange (“CSE”) under the symbol DOSE (“RDT” or the “Company“) announces the appointment of Mr. Peter Thilo Hasler to the board of directors. Mark Upsdell, CEO of RDT said...
August 11, 2020
Burlington, Ontario – August 11, 2020 – Rapid Dose Therapeutics Corp. trading on the Canadian Securities Exchange (“CSE”) under the symbol DOSE (“RDT” or the “Company“) announces that the Company, in conjunction with Leede Jones Gable, has received an initial advance from a strategic industry...
June 26, 2020
Burlington, Ontario – June 26, 2020 – Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Company”) announces that due to circumstances created by the COVID-19 pandemic, the Ontario Securities Commission and other members of the Canadian Securities Administrators granted “Issuers” in the Canadian securities...
June 19, 2020
BURLINGTON, Ontario – June 19, 2020 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian Life Sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has filed a non-provisional patent with the USPTO for...
May 29, 2020
BURLINGTON, Ontario – May 29, 2020 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian Life Sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has signed an agreement with Leede Jones Gable to...
April 2, 2020
Burlington, Ontario – April 2, 2020 – Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation”) in response to the COVID pandemic, recently made a donation to the Burlington Foodbank contributing over 16,000 QuickStrip™ Vitamin B12 product to distribute to those in need in...
March 31, 2020
Burlington, Ontario – March 31, 2020 – Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation“) is pleased to announce that RDT has completed its first shipment of QuickStrip™ nutraceutical products to Peter Pan Brands. The QuickStrip™ nutraceutical product line will be distributed by...